A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids

Sankar Devarajan, Biprabuddha Chatterjee, Hidenori Urata, Bo Zhang, Amanat Ali, Ravinder Singh, Sambandam Ganapathy

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Considering the health benefits of sesame oil and rice bran oil, the study was conducted to determine the extent to which the daily use of this blend of oils controls hyperglycemia and improves the lipid profile. Methods: In this 8-week open-label randomized dietary intervention study, 300 type 2 diabetes mellitus patients and 100 normoglycemic subjects were grouped as 1) normoglycemic subjects (n = 100) treated with sesame oil blend Vivo (Adani Wilmar, Ahmedabad, Gujarat, India), 2) type 2 diabetes mellitus patients treated with sesame oil blend (n = 100), 3) type 2 diabetes mellitus patients treated with glibenclamide (n = 100; 5 mg/d), and 4) type 2 diabetes mellitus patients treated in combination of glibenclamide (5 mg/d) and sesame oil blend (n = 100). Twelve-hour fasting blood glucose, glycated hemoglobin (HbA1c), and lipid profile followed by postprandial blood glucose were measured at baseline. Sesame oil blend was supplied to the respective groups, who were instructed to use as cooking oil for 8 weeks. Fasting and postprandial blood glucose was measured at week 4 and week 8, while HbA1c and lipid profile were measured at week 8. Results: At week 4 and week 8, type 2 diabetes mellitus patients treated with sesame oil blend or glibenclamide or combination of glibenclamide and sesame oil blend showed significant reduction of fasting and postprandial blood glucose (P

Original languageEnglish
JournalAmerican Journal of Medicine
DOIs
Publication statusAccepted/In press - 2016

Fingerprint

Sesamum
Sesame Oil
Hyperglycemia
Type 2 Diabetes Mellitus
Lipids
Glyburide
Blood Glucose
Fasting
Oils
Glycosylated Hemoglobin A
Cooking
Insurance Benefits
rice bran oil
India

Keywords

  • Hyperglycemia
  • Lipids
  • Sesame oil blend
  • Type 2 diabetes mellitus patients

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids. / Devarajan, Sankar; Chatterjee, Biprabuddha; Urata, Hidenori; Zhang, Bo; Ali, Amanat; Singh, Ravinder; Ganapathy, Sambandam.

In: American Journal of Medicine, 2016.

Research output: Contribution to journalArticle

Devarajan, Sankar ; Chatterjee, Biprabuddha ; Urata, Hidenori ; Zhang, Bo ; Ali, Amanat ; Singh, Ravinder ; Ganapathy, Sambandam. / A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids. In: American Journal of Medicine. 2016.
@article{f947d5cd0ee74050bfab0de74a9f9d8e,
title = "A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids",
abstract = "Background: Considering the health benefits of sesame oil and rice bran oil, the study was conducted to determine the extent to which the daily use of this blend of oils controls hyperglycemia and improves the lipid profile. Methods: In this 8-week open-label randomized dietary intervention study, 300 type 2 diabetes mellitus patients and 100 normoglycemic subjects were grouped as 1) normoglycemic subjects (n = 100) treated with sesame oil blend Vivo (Adani Wilmar, Ahmedabad, Gujarat, India), 2) type 2 diabetes mellitus patients treated with sesame oil blend (n = 100), 3) type 2 diabetes mellitus patients treated with glibenclamide (n = 100; 5 mg/d), and 4) type 2 diabetes mellitus patients treated in combination of glibenclamide (5 mg/d) and sesame oil blend (n = 100). Twelve-hour fasting blood glucose, glycated hemoglobin (HbA1c), and lipid profile followed by postprandial blood glucose were measured at baseline. Sesame oil blend was supplied to the respective groups, who were instructed to use as cooking oil for 8 weeks. Fasting and postprandial blood glucose was measured at week 4 and week 8, while HbA1c and lipid profile were measured at week 8. Results: At week 4 and week 8, type 2 diabetes mellitus patients treated with sesame oil blend or glibenclamide or combination of glibenclamide and sesame oil blend showed significant reduction of fasting and postprandial blood glucose (P",
keywords = "Hyperglycemia, Lipids, Sesame oil blend, Type 2 diabetes mellitus patients",
author = "Sankar Devarajan and Biprabuddha Chatterjee and Hidenori Urata and Bo Zhang and Amanat Ali and Ravinder Singh and Sambandam Ganapathy",
year = "2016",
doi = "10.1016/j.amjmed.2016.02.044",
language = "English",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - A Blend of Sesame and Rice Bran Oils Lowers Hyperglycemia and Improves the Lipids

AU - Devarajan, Sankar

AU - Chatterjee, Biprabuddha

AU - Urata, Hidenori

AU - Zhang, Bo

AU - Ali, Amanat

AU - Singh, Ravinder

AU - Ganapathy, Sambandam

PY - 2016

Y1 - 2016

N2 - Background: Considering the health benefits of sesame oil and rice bran oil, the study was conducted to determine the extent to which the daily use of this blend of oils controls hyperglycemia and improves the lipid profile. Methods: In this 8-week open-label randomized dietary intervention study, 300 type 2 diabetes mellitus patients and 100 normoglycemic subjects were grouped as 1) normoglycemic subjects (n = 100) treated with sesame oil blend Vivo (Adani Wilmar, Ahmedabad, Gujarat, India), 2) type 2 diabetes mellitus patients treated with sesame oil blend (n = 100), 3) type 2 diabetes mellitus patients treated with glibenclamide (n = 100; 5 mg/d), and 4) type 2 diabetes mellitus patients treated in combination of glibenclamide (5 mg/d) and sesame oil blend (n = 100). Twelve-hour fasting blood glucose, glycated hemoglobin (HbA1c), and lipid profile followed by postprandial blood glucose were measured at baseline. Sesame oil blend was supplied to the respective groups, who were instructed to use as cooking oil for 8 weeks. Fasting and postprandial blood glucose was measured at week 4 and week 8, while HbA1c and lipid profile were measured at week 8. Results: At week 4 and week 8, type 2 diabetes mellitus patients treated with sesame oil blend or glibenclamide or combination of glibenclamide and sesame oil blend showed significant reduction of fasting and postprandial blood glucose (P

AB - Background: Considering the health benefits of sesame oil and rice bran oil, the study was conducted to determine the extent to which the daily use of this blend of oils controls hyperglycemia and improves the lipid profile. Methods: In this 8-week open-label randomized dietary intervention study, 300 type 2 diabetes mellitus patients and 100 normoglycemic subjects were grouped as 1) normoglycemic subjects (n = 100) treated with sesame oil blend Vivo (Adani Wilmar, Ahmedabad, Gujarat, India), 2) type 2 diabetes mellitus patients treated with sesame oil blend (n = 100), 3) type 2 diabetes mellitus patients treated with glibenclamide (n = 100; 5 mg/d), and 4) type 2 diabetes mellitus patients treated in combination of glibenclamide (5 mg/d) and sesame oil blend (n = 100). Twelve-hour fasting blood glucose, glycated hemoglobin (HbA1c), and lipid profile followed by postprandial blood glucose were measured at baseline. Sesame oil blend was supplied to the respective groups, who were instructed to use as cooking oil for 8 weeks. Fasting and postprandial blood glucose was measured at week 4 and week 8, while HbA1c and lipid profile were measured at week 8. Results: At week 4 and week 8, type 2 diabetes mellitus patients treated with sesame oil blend or glibenclamide or combination of glibenclamide and sesame oil blend showed significant reduction of fasting and postprandial blood glucose (P

KW - Hyperglycemia

KW - Lipids

KW - Sesame oil blend

KW - Type 2 diabetes mellitus patients

UR - http://www.scopus.com/inward/record.url?scp=84967214193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84967214193&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2016.02.044

DO - 10.1016/j.amjmed.2016.02.044

M3 - Article

C2 - 27046245

AN - SCOPUS:84967214193

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

ER -